Journal of Nuclear Medicine: 63 (2)

February 1, 2022; Volume 63,Issue 2

This Month in JNM

You have access
This Month in JNM
Journal of Nuclear Medicine February 1, 2022, 63 (2) 10A;

Discussions with Leaders

You have access
A European Oncology Leader Looks at PSMA
Silke Gillessen, Johannes Czernin and Ken Herrmann

Journal of Nuclear Medicine February 1, 2022, 63 (2) 169-171; DOI: https://doi.org/10.2967/jnumed.121.263729

The State of The Art

You have access
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
Fanny Orlhac, Jakoba J. Eertink, Anne-Ségolène Cottereau, Josée M. Zijlstra, Catherine Thieblemont, Michel Meignan, Ronald Boellaard and Irène Buvat

Journal of Nuclear Medicine February 1, 2022, 63 (2) 172-179; DOI: https://doi.org/10.2967/jnumed.121.262464

Hot Topics

You have access
Is It Too Soon to Know When It’s LATE?
Angela C. Rieger and Daniel H.S. Silverman

Journal of Nuclear Medicine February 1, 2022, 63 (2) 180-182; DOI: https://doi.org/10.2967/jnumed.121.263229

Focus on Molecular Imaging

You have access
Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox
Chao Li, Chaozhe Han, Shao Duan, Ping Li, Israt S. Alam and Zunyu Xiao

Journal of Nuclear Medicine February 1, 2022, 63 (2) 183-188; DOI: https://doi.org/10.2967/jnumed.121.261976

Standard Of Care

You have access
Management of Differentiated Thyroid Cancer: The Standard of Care
Anca M. Avram, Katherine Zukotynski, Helen Ruth Nadel and Luca Giovanella

Journal of Nuclear Medicine February 1, 2022, 63 (2) 189-195; DOI: https://doi.org/10.2967/jnumed.121.262402

Editorial

You have access
Managing a High-Specific-Activity Iobenguane Therapy Clinic: From Operations to Reimbursement
Sophia R. O’Brien and Daniel A. Pryma

Journal of Nuclear Medicine February 1, 2022, 63 (2) 196-198; DOI: https://doi.org/10.2967/jnumed.121.262306

Oncology

Clinical
- You have access
  18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
  Matthias R. Benz, Wesley R. Armstrong, Francesco Ceci, Giulia Polverari, Timothy R. Donahue, Zev A. Wainberg, Andrew Quon, Martin Auerbach, Mark D. Girgis, Ken Herrmann, Johannes Czernin and Jeremie Calais
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 199-204; DOI: https://doi.org/10.2967/jnumed.121.261952
- You have access
  ¹³¹I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors
  Ying Zhang, Juergen Kupferschlaeger, Peter Lang, Gerald Reischl, Rupert J. Handgretinger, Christian la Fougère and Helmut Dittmann
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 205-211; DOI: https://doi.org/10.2967/jnumed.120.261854

Theranostics

Clinical
- You have access
  Detecting Fibroblast Activation Proteins in Lymphoma Using ⁶⁸Ga-FAPI PET/CT
  Xiao Jin, Maomao Wei, Shuailiang Wang, Guochang Wang, Yumei Lai, Yunfei Shi, Yan Zhang, Zhi Yang and Xuejuan Wang
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 212-217; DOI: https://doi.org/10.2967/jnumed.121.262134
- You have access
  Efficacy and Safety of ¹⁷⁷Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
  Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J. Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J. Hicks, Simona Grozinsky-Glasberg and Grace Kong
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 218-225; DOI: https://doi.org/10.2967/jnumed.120.260760
- You have access
  Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET: Myth or Reality?
  Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler and Matthias Eiber
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 226-232; DOI: https://doi.org/10.2967/jnumed.121.261906
- You have access
  aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in ¹⁸F-DCFPyL Images of Veterans with Prostate Cancer
  Nicholas Nickols, Aseem Anand, Kerstin Johnsson, Johan Brynolfsson, Pablo Borreli, Neil Parikh, Jesus Juarez, Lida Jafari, Mattias Eiber and Matthew Rettig
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 233-239; DOI: https://doi.org/10.2967/jnumed.120.261863
- Open Access
  Diagnostic Performance and Clinical Impact of ⁶⁸Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
  Juliano J. Cerci, Stefano Fanti, Enrique E. Lobato, Jolanta Kunikowska, Omar Alonso, Sevastian Medina, Fuad Novruzov, Thabo Lengana, Carlos Granados, Rakesh Kumar, Venkatesh Rangarajan, Akram Al-Ibraheem, Mukbil Hourani, Nor S. Ali, Azra Ahmad, Zohar Keidar, Ozlem Küçük, Umut Elboga, Mateos Bogoni and Diana Paez
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 240-247; DOI: https://doi.org/10.2967/jnumed.120.261886
- BRIEF COMMUNICATION
  - You have access
    The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
    Liang Dong, Yun Su, Yinjie Zhu, Mark C. Markowski, Mei Xin, Michael A. Gorin, Baijun Dong, Jiahua Pan, Martin G. Pomper, Jianjun Liu, Kenneth J. Pienta, Wei Xue and Steven P. Rowe
    
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 248-252; DOI: https://doi.org/10.2967/jnumed.121.262411
- You have access
  Kidney Doses in ¹⁷⁷Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
  Michael Mix, Tobias Renaud, Felix Kind, Ursula Nemer, Elham Yousetzadeh-Nowsha, Tumelo C.G. Moalosi, Aymen M. Ormrane, Philipp T. Meyer and Juri Ruf
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.121.262245
Basic
- FEATURED BASIC SCIENCE ARTICLE
  - You have access
    An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy
    Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper
    
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098

Infectious Disease

Clinical
- INVITED PERSPECTIVE
  - You have access
    Imaging in Post-COVID Lung Disease: Does ¹⁸F-FDG PET/CT Have the Key?
    Olivier Gheysens, Leïla Belkhir and François Jamar
    
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 268-269; DOI: https://doi.org/10.2967/jnumed.121.263166
- BRIEF COMMUNICATION
  - Open Access
    Evolution of ¹⁸F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
    Andrew Thornton, Francesco Fraioli, Simon Wan, Helen S. Garthwaite, Balaji Ganeshan, Robert I. Shortman, Raymond Endozo, Stefan Vöö, Irfan Kayani, Deena Neriman, Leon Menezes, Jamshed Bomanji, Toby Hilllman, Melissa Heightman, Joanna C. Porter and Ashley M. Groves
    
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 270-273; DOI: https://doi.org/10.2967/jnumed.121.262296
- Open Access
  Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing ¹⁸F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes
  Cristina Gamila Wakfie-Corieh, Federico Ferrando-Castagnetto, Alba María Blanes García, Marta García García-Esquinas, Aída Ortega Candil, Cristina Rodríguez Rey, María Nieves Cabrera-Martín, Ana Delgado Cano and José Luis Carreras Delgado
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 274-279; DOI: https://doi.org/10.2967/jnumed.121.261915

Cardiovascular

Clinical
- You have access
  Comparing Semiquantitative and Qualitative Methods of Vascular ¹⁸F-FDG PET Activity Measurement in Large-Vessel Vasculitis
  Himanshu R. Dashora, Joel S. Rosenblum, Kaitlin A. Quinn, Hugh Alessi, Elaine Novakovich, Babak Saboury, Mark A. Ahlman and Peter C. Grayson
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 280-286; DOI: https://doi.org/10.2967/jnumed.121.262326

Neurology

Clinical
- You have access
  Dynamic Amyloid PET: Relationships to ¹⁸F-Flortaucipir Tau PET Measures
  Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson and Jonathan McConathy
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.120.254490
Basic
- You have access
  Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots
  Javad Khodaii, Mostafa Araj-Khodaei, Manouchehr S. Vafaee, Dean F. Wong and Albert Gjedde
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 294-301; DOI: https://doi.org/10.2967/jnumed.117.204453
- Open Access
  ¹¹C-PiB and ¹²⁴I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
  Silvio R. Meier, Dag Sehlin, Sahar Roshanbin, Victoria Lim Falk, Takashi Saito, Takaomi C. Saido, Ulf Neumann, Johanna Rokka, Jonas Eriksson and Stina Syvänen
  
  Journal of Nuclear Medicine February 1, 2022, 63 (2) 302-309; DOI: https://doi.org/10.2967/jnumed.121.262083

Endocrinology

Clinical
- FEATURED ARTICLE OF THE MONTH
  - Open Access
    ⁶⁸Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
    Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Vikas Prasad, Sonal Prasad, Paolo de Coppi, Peter Kühnen, Mijke Buitinga, Pirjo Nuutila, Timo Otonkoski, Khalid Hussain, Maarten Brom, Annemarie Eek, Jamshed Bomanji, Pratik Shah and Martin Gotthardt
    
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 310-315; DOI: https://doi.org/10.2967/jnumed.121.262327

Special Contribution

You have access
RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 1—Collection of Data for Radiopharmaceutical Dosimetry
Michael G. Stabin, Richard E. Wendt and Glenn D. Flux

Journal of Nuclear Medicine February 1, 2022, 63 (2) 316-322; DOI: https://doi.org/10.2967/jnumed.120.259200

Letters To The Editor

You have access
Commercially Competitive Vendor-Agnostic Image Reconstruction Could Be a Leap Forward for PET Harmonization
Adam L Kesner

Journal of Nuclear Medicine February 1, 2022, 63 (2) 323-324; DOI: https://doi.org/10.2967/jnumed.121.263421
You have access
A VISION of ALSYMPCA
Paulo Schiavom Duarte

Journal of Nuclear Medicine February 1, 2022, 63 (2) 324; DOI: https://doi.org/10.2967/jnumed.121.263160
You have access
Reply: A VISION of ALSYMPCA
Oliver Sartor

Journal of Nuclear Medicine February 1, 2022, 63 (2) 324-325; DOI: https://doi.org/10.2967/jnumed.121.263193
You have access
On Semiquantitative Methods for Assessing Vascular ¹⁸F-FDG PET Activity in Large-Vessel Vasculitis
Eric Laffon and Roger Marthan

Journal of Nuclear Medicine February 1, 2022, 63 (2) 325-326; DOI: https://doi.org/10.2967/jnumed.121.263060
You have access
Reply: On Semiquantitative Methods for Assessing Vascular ¹⁸F-FDG PET Activity in Large-Vessel Vasculitis
Mark A. Ahlman, Roberto Maass-Moreno and Peter C. Grayson

Journal of Nuclear Medicine February 1, 2022, 63 (2) 326; DOI: https://doi.org/10.2967/jnumed.121.263158

Erratum

You have access
Erratum
Journal of Nuclear Medicine February 1, 2022, 63 (2) 252;

SNMMI Newsline

You have access
SNMMI Newsline
Journal of Nuclear Medicine February 1, 2022, 63 (2) 23N-34N;
You have access
Joint NIBIB/NCI/SNMMI Workshop on Directly Imaging Targeted Radionuclide Therapy Isotopes
I. George Zubal and Jacek Capala

Journal of Nuclear Medicine February 1, 2022, 63 (2) 23N-25N;
You have access
DOE and HHS Certify Sufficient ⁹⁹Mo Supplies
Journal of Nuclear Medicine February 1, 2022, 63 (2) 26N;
You have access
FDA Approves New ⁶⁸Ga Kit for Prostate Cancer PET
Journal of Nuclear Medicine February 1, 2022, 63 (2) 26N;
You have access
SNMMI to Host Summits on Artificial Intelligence and Patient Access
Richard L. Wahl

Journal of Nuclear Medicine February 1, 2022, 63 (2) 27N;
You have access
Newsbriefs
Journal of Nuclear Medicine February 1, 2022, 63 (2) 28N-29N;
You have access
From the Literature
Journal of Nuclear Medicine February 1, 2022, 63 (2) 30N-34N;

Main menu

User menu

Search

Table of Contents

This Month in JNM

Discussions with Leaders

The State of The Art

Hot Topics

Focus on Molecular Imaging

Standard Of Care

Editorial

Oncology

Clinical

Theranostics

Clinical

BRIEF COMMUNICATION

Basic

FEATURED BASIC SCIENCE ARTICLE

Infectious Disease

Clinical

INVITED PERSPECTIVE

BRIEF COMMUNICATION

Cardiovascular

Clinical

Neurology

Clinical

Basic

Endocrinology

Clinical

FEATURED ARTICLE OF THE MONTH

Special Contribution

Letters To The Editor

Erratum

SNMMI Newsline

In this issue

Issue highlights

Jump to